Searched for
CAIRNHILL CIPEF LTD
ChrysCapital, Capital Group sell 7.6% in Mankind for Rs 5,589 croreOn the BSE, Kotak Funds India Midcap Fund acquired 2.0 million shares of at an average price of ₹1,832.30 apiece, taking the deal size to ₹...- Mankind Pharma IPO subscribed 15.32 timesThis will be one of the largest public issues by a domestic drug manufacturer after the ₹6,480-crore IPO of Gland Pharma in 2020. The quali...
- Mankind Pharma IPO: 10 things to know about the biggest issue so far this yearIndian pharma company Mankind Pharma is set to open its IPO next week. The offer for sale of 40 million equity shares by promoters and othe...
- Mankind Pharma announces IPO price band at Rs 1,026-1,080At the upper end of the price band, the fourth largest pharmaceutical company in terms of domestic sales will be valued at ₹43,264 crore. T...
- Mankind Pharma sets IPO price band at Rs 1,026-1,080The IPO is entirely an offer for sale (OFS) by promoters and existing investors who are looking to divest their stakes in the Delhi-based p...
- Mankind Pharma IPO to open for subscription on April 25The company has hired Kotak Investment Banking, Axis Capital, IIFL Securities, Jefferies and JP Morgan as book-running lead managers while ...
- FIPB clears 16 FDI proposals worth Rs 1,153 croreFIPB today cleared 16 foreign direct investment proposals amounting to Rs 1,152.53 crore, including that of Edelweiss Tokio Life Insurance,...
- CCI approves Mankind Pharma's 11% stake sale to PE investorsApproving the deal, the fair trade regulator said the transaction is not likely to have any appreciable adverse effect on competition in In...
- CCI nod to Mankind Pharma acquisition by Cairnhill CIPEF and Cairnhill CGPE.The Competition Commission of India (CCI) has approved acquisition of 11% equity shares of Mankind Pharma by global private equity firm Cai...
Load More
